Evidence map›Paper›PMID 26151925›Full record

ArticleTranslational psychiatry2015

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

A Frick, F Ahs, C Linnman, M Jonasson, L Appel, M Lubberink, B Långström, M Fredrikson, T Furmark

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

A FrickDepartment of Psychology, Uppsala University, Uppsala, Sweden.ORCID 0000000325169075
F Ahs1] Department of Psychology, Uppsala University, Uppsala, Sweden [2] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
C LinnmanCenter for Pain and the Brain, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
M JonassonDepartment of Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden.
L AppelDepartment of Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden.
M LubberinkDepartment of Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden.
B LångströmDepartment of Chemistry, Uppsala University, Uppsala, Sweden.
M Fredrikson1] Department of Psychology, Uppsala University, Uppsala, Sweden [2] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
T FurmarkDepartment of Psychology, Uppsala University, Uppsala, Sweden.
Uppsala University · SEBoston Children's Hospital · USScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurokinin-1 (NK1) receptor is abundantly expressed in the fear circuitry of the brain, including the amygdala, where it modulates stress and anxiety. Despite its proposed involvement in psychopathology, only a few studies of NK1 receptor availability in human subjects with anxiety disorders exist. Here, we compared NK1 receptor availability in patients with social anxiety disorder (SAD; n = 17) and healthy controls (n = 17) using positron emission tomography and the radiotracer [11C]GR205171. The Patlak Graphical plot using a cerebellar reference region was used to model the influx parameter, Ki measuring NK1 receptor availability. Voxel-wise statistical parametric mapping analyses revealed increased NK1 receptor availability specifically in the right amygdala in SAD patients relative to controls. Thus, we demonstrate that exaggerated social anxiety is related to enhanced NK1 receptor availability in the amygdala. This finding supports the contribution of NK1 receptors not only in animal models of stress and anxiety but also in humans with anxiety disorders.

Indexed as

AdultAmygdalaCase-Control StudiesFemaleHumansMaleNeuroimagingNeurokinin-1 Receptor AntagonistsPhobic DisordersPiperidinesPositron-Emission TomographyReceptors, Neurokinin-1TetrazolesNeurokinin-1 Receptor AntagonistsPiperidinesReceptors, Neurokinin-1Tetrazolesvofopitant

Identifiers

PMID26151925
PMCPMC5068728
OpenAlexW1490940514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.